# The National Institute for Health and Care Excellence (Constitution and Functions) and NHS England (Information Functions) Regulations 2013, Regulation 2: Interpretation of this Part

Extent: E+W

In this Part—
“carer” means an adult who provides or intends to provide care for another person;
...
“Directive 2001/83/EC” means Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use;
“health technology” may include—
(a)a medicinal product to which Directive 2001/83/EC applies;
(b)a medical device;
(c)a diagnostic technique;
(d)a surgical procedure or other therapeutic technique;
(e)a therapeutic technology other than a medicinal product to which Directive 2001/83/EC applies, medical device, diagnostic technique or surgical procedure;
(f)a system of care; or
(g)a screening tool;
“highly specialised health technology” means a health technology intended for use in the provision of services for rare and very rare conditions provided for in regulations under section 3B(1)(d) of the 2006 Act;
“highly specialised technology recommendation” means a recommendation made by NICE following an appraisal of the benefits and costs of a highly specialised health technology conducted by NICE in accordance with NICE’s published methods and processes for appraisal of highly specialised health technologies that results in a positive assessment;
“integrated care board” means an integrated care board established under Chapter A3 of Part 2 of the 2006 Act;
“the Institute” means the Special Health Authority known as the National Institute for Health and Clinical Excellence;
“life sciences industry” includes the pharmaceutical, medical technology and medical biotechnology industries;
“NICE” means the National Institute for Health and Care Excellence established under section 232 of the Act;
“patient” means any person who is receiving treatment as part of the health service in England;
“technology appraisal recommendation” means a recommendation made by NICE following an appraisal of the benefits and costs of a health technology conducted by NICE in accordance with NICE’s published methods and processes for appraisal of health technologies that results in a positive assessment (but does not include a highly specialised technology recommendation);
“treatment” means an intervention that is intended to manage a person’s disease, condition or injury and includes prevention, examination and diagnosis.

---
Source: https://www.legislation.gov.uk/uksi/2013/259/regulation/2 (the official version)
Page: https://openlegislation.uk/national-institute-for-health-and-care-excellence-constitution-and-functions-and-nhs-england-information-functions-regulations-2013/regulation-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

